Cancer treatment may inhibit immune response to COVID-19 vaccination

A study has found that patients with cancer who receive chemotherapy — and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells — may mount an inadequate immune response to COVID-19 vaccination.


Click here for original story, Cancer treatment may inhibit immune response to COVID-19 vaccination


Source: ScienceDaily